Cargando…
Prospective multi-center dosimetry study of low-dose Iodine-125 prostate brachytherapy performed after transurethral resection
PURPOSE: To evaluate in a multicenter setting the ability of centers to perform pre-implant permanent prostate brachytherapy planning, fulfilling dosimetric goals and constraints based on the Groupe de Curiethérapie-European Society for Radiotherapy and Oncology guidelines in the setting of implanta...
Autores principales: | Salembier, Carl, Rijnders, Alex, Henry, Ann, Niehoff, Peter, André Siebert, Frank, Hoskin, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708148/ https://www.ncbi.nlm.nih.gov/pubmed/23878549 http://dx.doi.org/10.5114/jcb.2013.36174 |
Ejemplares similares
-
A history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate (125)I prostate brachytherapy: results of a prospective Uro-GEC phase-II trial
por: Salembier, Carl, et al.
Publicado: (2020) -
Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma
por: Wang, Congxiao, et al.
Publicado: (2022) -
Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020) -
Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
por: Du, E, et al.
Publicado: (2017) -
Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2019)